FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

McKnight James Reed Jr. 		2. Issuer Name and Ticker or Trading Symbol

Diversicare Healthcare Services, Inc. [ DVCR ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Financial Officer
(Last)          (First)          (Middle)

1621 GALLERIA BOULEVARD 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/31/2018
(Street)

BRENTWOOD, TN 37027
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  86506   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Dividend Equivalent Rights on 2018 Restricted Shares     (1) 3/31/2018     A      91.42         (1)   (1) Common Stock   91.42   $0.00   (1) 91.42   D    
Dividend Equivalent Rights on 2017 Restricted Shares     (2) 3/31/2018     A      62.27         (2)   (2) Common Stock   62.27   $0.00   (2) 242.41   D    
Dividend Equivalent Rights on 2016 Restricted Shares     (3) 3/31/2018     A      31.89         (3)   (3) Common Stock   31.89   $0.00   (3) 224.57   D    
2018 Restricted Stock Units     (4) 3/31/2018     A      27.95         (5)   (5) Common Stock   27.95   $0.00   3849.05   D    
2017 Restricted Stock Units     (4) 3/31/2018     A      32.3         (6)   (6) Common Stock   32.3   $0.00   4449.21   D    

Explanation of Responses:
(1)  These dividend equivalent rights accrued on shares of restricted stock granted on March 13, 2018 and will vest as the underlying shares vest.
(2)  These dividend equivalent rights accrued on shares of restricted stock granted on March 13, 2017 and will vest as the underlying shares vest.
(3)  These dividend equivalent rights accrued on shares of restricted stock granted on March 11, 2016 and will vest as the underlying shares vest.
(4)  Each restricted stock unit is equal to one share. These are dividend equivalent rights accruing on restricted stock units.
(5)  The 2018 Restricted Stock Units shall vest and be exercisable in full on the 2nd anniversary of their original Grant Date (03/13/2018).
(6)  The 2017 Restricted Stock Units shall vest and be exercisable in full on the 2nd anniversary of their original Grant Date (03/13/2017).

Remarks:
Exhibit List
Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
McKnight James Reed Jr.
1621 GALLERIA BOULEVARD
BRENTWOOD, TN 37027

Chief Financial Officer

Signatures
/s/ Susan V. Sidwell, Attorney-In-Fact for James Reed McKnight, Jr. 4/3/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Diversicare Healthcare S... (NASDAQ:DVCR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Diversicare Healthcare S... Charts.
Diversicare Healthcare S... (NASDAQ:DVCR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Diversicare Healthcare S... Charts.